In October 2018, the president signed the SUPPORT for Patients and Communities Act, which addresses multiple aspects of the opioid crisis. Several provisions in the bill are slated to increase access to medication-assisted treatment (MAT), in which buprenorphine or another medication is part of the treatment plan for substance use disorder. Specifically, the bill: